Avidity Biosciences (RNA) News Today $45.70 +1.52 (+3.43%) As of 02:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Avidity Biosciences (NASDAQ:RNA) Shares Down 7.6% - Here's What HappenedSeptember 29, 2025 | marketbeat.comAssenagon Asset Management S.A. Has $507,000 Position in Avidity Biosciences, Inc. $RNASeptember 28, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Avidity Biosciences (RNA), Crinetics Pharmaceuticals (CRNX)September 24, 2025 | theglobeandmail.comAvidity Biosciences (RNA) Announces Positive One-Year Data For its, Del-ZotaSeptember 24, 2025 | msn.comSteven George Hughes Sells 2,208 Shares of Avidity Biosciences (NASDAQ:RNA) StockSeptember 24, 2025 | insidertrades.comAvidity Biosciences (NASDAQ:RNA) Given New $65.00 Price Target at Evercore ISISeptember 24, 2025 | americanbankingnews.comAvidity Biosciences (NASDAQ:RNA) Insider Sells $89,600.64 in StockSeptember 23, 2025 | marketbeat.comEvercore ISI Cuts Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00September 22, 2025 | marketbeat.comFinancial Contrast: Avidity Biosciences (NASDAQ:RNA) & Repare Therapeutics (NASDAQ:RPTX)September 22, 2025 | americanbankingnews.comWhat is Roth Capital's Estimate for RNA Q3 Earnings?September 20, 2025 | marketbeat.comRoth Capital Initiates Coverage of Avidity Biosciences (RNA) with Buy RecommendationSeptember 18, 2025 | msn.comAvidity Biosciences (NASDAQ:RNA) Coverage Initiated at Roth CapitalSeptember 18, 2025 | marketbeat.comMirador Capital Partners LP Has $1.18 Million Position in Avidity Biosciences, Inc. $RNASeptember 18, 2025 | marketbeat.comVoya Investment Management LLC Has $9.81 Million Stake in Avidity Biosciences, Inc. $RNASeptember 17, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Trading Down 5.3% - Here's What HappenedSeptember 16, 2025 | marketbeat.comBank of America Issues Positive Forecast for Avidity Biosciences (NASDAQ:RNA) Stock PriceSeptember 16, 2025 | marketbeat.comAvidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional SharesSeptember 15, 2025 | prnewswire.comRhumbline Advisers Has $4.86 Million Stock Position in Avidity Biosciences, Inc. $RNASeptember 15, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Shares Gap Up on Analyst UpgradeSeptember 14, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Given New $87.00 Price Target at HC WainwrightSeptember 14, 2025 | marketbeat.comAvidity Biosciences (RNA) Gets 9% Boost from Higher PT, RatingSeptember 13, 2025 | msn.comAvidity Biosciences (NASDAQ:RNA) Shares Gap Down - What's Next?September 13, 2025 | marketbeat.comAvidity Biosciences reports data from DMD treatment trialsSeptember 12, 2025 | msn.comAvidity Biosciences (NASDAQ:RNA) Given New $65.00 Price Target at Needham & Company LLCSeptember 12, 2025 | marketbeat.comAvidity Biosciences' (RNA) "Buy" Rating Reaffirmed at Chardan CapitalSeptember 12, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Director Troy Edward Wilson Sells 29,500 SharesSeptember 11, 2025 | marketbeat.comAvidity Biosciences Announces Pricing of Upsized Public Offering of Common StockSeptember 11, 2025 | prnewswire.comAvidity Biosciences: Maintaining 'Strong Buy' Rating Based On Accelerated Approval Filing For Del-ZotaSeptember 11, 2025 | seekingalpha.comWhy Is Avidity Biosciences Stock Down 20% Pre-market Today?September 11, 2025 | msn.comAvidity Shares Climb on Promising DMD44 Trial Results for Del-zotaSeptember 11, 2025 | msn.comAvidity Biosciences, Inc. (RNA) Discusses On Redefining The Treatment Of Duchenne Muscular Dystrophy (Transcript)September 10, 2025 | seekingalpha.comCantor finds Avidity data highly supportive of del-zota best-in-class potentialSeptember 10, 2025 | msn.comDeep Dive Into Avidity Biosciences Stock: Analyst Perspectives (8 Ratings)September 10, 2025 | benzinga.comAvidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living ...September 10, 2025 | finance.yahoo.comRedefining the Treatment of Duchenne Muscular Dystrophy PresentationSeptember 10, 2025 | seekingalpha.comAvidity Biosciences Announces Proposed Public Offering of Common StockSeptember 10, 2025 | prnewswire.comAvidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44September 10, 2025 | prnewswire.comTroy Edward Wilson Sells 29,500 Shares of Avidity Biosciences (NASDAQ:RNA) StockSeptember 10, 2025 | insidertrades.comCantor Fitzgerald Reiterates a Buy Rating on Avidity Biosciences (RNA)September 10, 2025 | insidermonkey.comAvidity Biosciences, Inc. (RNA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comAlyeska Investment Group L.P. Has $2.95 Million Stock Holdings in Avidity Biosciences, Inc. $RNASeptember 8, 2025 | marketbeat.comRaymond James Financial Inc. Sells 39,643 Shares of Avidity Biosciences, Inc. $RNASeptember 8, 2025 | marketbeat.comAvidity Biosciences, Inc. (RNA) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comAvidity Biosciences’ Promising Phase 3 Study on Del-desiran for DM1: What Investors Need to KnowSeptember 7, 2025 | msn.comEFG Asset Management North America Corp. Raises Stock Holdings in Avidity Biosciences, Inc. $RNASeptember 6, 2025 | marketbeat.comEric Mosbrooker Sells 6,563 Shares of Avidity Biosciences (NASDAQ:RNA) StockSeptember 6, 2025 | insidertrades.comAvidity Biosciences, Inc. $RNA Shares Sold by Cormorant Asset Management LPSeptember 6, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Has $63.35 Million Stock Position in Avidity Biosciences, Inc. $RNASeptember 5, 2025 | marketbeat.comAvidity Biosciences, Inc. (RNA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeptember 5, 2025 | seekingalpha.comMPM Bioimpact LLC Has $21.08 Million Stake in Avidity Biosciences, Inc. $RNASeptember 4, 2025 | marketbeat.com Get Avidity Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RNA Media Mentions By Week RNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNA News Sentiment▼1.410.53▲Average Medical News Sentiment RNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNA Articles This Week▼29▲RNA Articles Average Week Get the Latest News and Ratings for RNA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BioNTech News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Summit Therapeutics News Today Dr. Reddy's Laboratories News Today Ascendis Pharma A/S News Today Viatris News Today Roivant Sciences News Today QIAGEN News Today Elanco Animal Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNA) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
